Andromedical

What Andromedical does

Andromedical S.L. is a Spanish privately-held medical device manufacturer founded in 2000 by Dr. Eduardo Gómez de Diego, headquartered in Madrid with a US subsidiary (Androshopping LLC) in Delaware. The company develops and sells non-invasive, non-surgical devices for male sexual health across four clinical indications: penis enlargement (Andropenis Pro, Gold, Mini, Comfort), Peyronie's disease and penile curvature (Andropeyronie), post-surgical penile rehabilitation after prostate or penile surgery (Androsurgery), and drug-free erectile dysfunction treatment (Androvacuum Manual and Premium). The company also markets an Andropharma supplement line for combined therapy and accessories/replacement kits for recurring revenue.

The underlying technology is mechanical rather than digital: penile traction therapy applies controlled, continuous tension to penile tissue to stimulate cellular proliferation and tissue growth, while vacuum erection devices create vacuum pressure to induce blood flow and erections. The portfolio is protected by international patents (USA, China, India since 2007) and certified under FDA Class II registration, CE Mark, and ISO 13485:2003, with clinical efficacy demonstrated in peer-reviewed publications in the British Journal of Urology International and Journal of Sexual Medicine showing outcomes of 1-4 cm length increase, 0.5-1.5 cm girth increase, up to 60% curvature reduction, and over 90% efficacy for erectile dysfunction. The company claims the #1 worldwide position in medical penis extender sales, over 1 million satisfied users, endorsement from approximately 7,000 urologists, and media coverage in Time, Men's Health, NYT, Fox News, and other major outlets.

Andromedical operates a product-led, direct-to-consumer model with primary revenue from one-time hardware sales (devices priced at €159-€399) supplemented by recurring accessory, replacement part (€79 per kit), and supplement (€69-€79 for 4-month supply) revenue. Distribution combines the company's own e-commerce store, Amazon storefronts across 20+ country marketplaces, eBay stores in 6 countries, UPS logistics, and a wholesale/retail partner program with minimum 5-unit opening orders. With 11-50 employees, the business remains small and founder-controlled with no disclosed external funding; products ship globally via UPS to over 165 countries with free shipping and discreet packaging.

Name

Andromedical

Legal name

Andromedical S.L.

Website

https://andromedical.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Andromedical S.L., founded in 2000 in Spain, develops patented, non-invasive penile traction and vacuum erection devices for male sexual health—including penis enlargement, Peyronie's disease, post-surgical rehabilitation, and erectile dysfunction—sold globally via DTC e-commerce and Amazon across 100+ countries.

Ownership category

akta.pro rank

Product category

Men's Health Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Men’s Health (OTC Urologic & Sexual Health) (HLAIADAK)

akta.pro secondary industry

Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH)

Keywords

• Penile traction devices
• Vacuum erection devices
• Men's health medical devices
• Peyronie's disease treatment
• Penis enlargement devices

Headquarters

HQ city

Lewes

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Medical Device Sales: One-time purchase model for penile traction devices, vacuum pumps, and accessories sold directly through e-commerce store and marketplaces. Primary revenue stream from devices ranging from €159 to €399.
2. Accessories and Replacement Parts: Replacement accessories including comfort kits, parts kits, rings, bands, silicone components, tops, motors, and cylinders sold at €79 per kit. Recurring revenue from consumables and wear items.
3. Men's Health Supplements: Andropharma supplement line including penis enhancement, curvature correction, and libido booster products sold as 4-month supply packages.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Core offering

Andromedical designs, manufactures and sells patented, FDA-registered, CE-marked medical devices for non-invasive and non-surgical men's urological treatments. Its product lines are penile traction devices (Andropenis for penis enlargement, Andropeyronie for Peyronie's disease/curvature, Androsurgery for post-prostate/penile surgery rehabilitation) and a vacuum erection device (Androvacuum) for drug-free erectile dysfunction treatment, complemented by the Andropharma supplement line and a full accessories/replacement-parts range. Devices are sold primarily direct-to-consumer through the company's own e-commerce store and through Amazon and eBay marketplaces in 100+ countries, supported by physician-reviewed product recommendations.

Product overview

Andromedical offers a comprehensive portfolio of medical-grade devices and supplements for men's health. The core product line consists of penile traction devices (Andropenis Pro, Andropenis Gold, Andropenis Mini, Andropeyronie, Androsurgery) that apply controlled traction for penis enlargement and curvature correction, and vacuum erection devices (Androvacuum Manual and Premium) for treating erectile dysfunction. These devices are complemented by the Andropharma supplement line (Penis, Curvature, Vigor) designed for combined therapy. The company provides extensive accessory kits and replacement parts to support device longevity. All devices are clinically tested, medically certified (ISO 13485, CE Mark, FDA registered), and supported by published clinical studies in peer-reviewed journals.

Differentiator

Problem solved

Functional benefit

Brands

• Andropenis: Medical penis extender for penis enlargement - patented device based on penile traction therapy
• Andropeyronie
• Androsurgery
• Androvacuum
• Andropharma

Products and services

• Andropenis Pro Patented medical penis extender for permanent penis enlargement via penile traction therapy; for men with penises longer than 10 cm erect; 2-month basic kit with rods, tubes, bands, rings and instruction booklet; priced at £159 / €179 / $199 / CA$269 / AU$299.
• Andropenis Gold Premium 24K gold-covered penis extender for permanent penis enlargement, with travel bag and same penile traction technology as Andropenis Pro; priced at £179 / €199 / $229 / CA$319 / AU$349.
• Andropenis Mini

Quantifiable outcome

• Penis length increase of 1-4 cm after 4 months of consistent use
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• AmazoncoreChannel Partner/ Reseller/ DistributorAmazon serves as a major marketplace channel partner with dedicated storefronts across 20+ countries including USA, Canada, Australia, UK, Germany, France, Italy, Netherlands, Belgium, Czech, Spain, Mexico, Portugal, Sweden, Poland, Japan, Singapore, Turkey, UAE, and Saudi Arabia. Products are sold through official Amazon shops with standard marketplace terms including applicable sales tax.
• eBayminorChannel Partner/ Reseller/ DistributoreBay marketplace presence across 6 country stores including USA-Canada, UK, Germany, France, Spain, and Italy. Provides additional marketplace reach for customers preferring eBay purchasing.
• UPSminorOthersUPS serves as the primary logistics and shipping partner for order fulfillment. Andromedical offers UPS fast shipping with tracking capabilities for global deliveries.
• U.S. Food and Drug Administration (FDA)coreOthersFDA registered medical device manufacturer. Andromedical holds FDA Class II device registration (LPCD=LKY) for Andropenis, Andropeyronie, and Androvacuum as external penile rigidity devices.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Boston Scientific (AMS Men's Health): Boston Scientific owns the AMS men's health franchise including penile implants (AMS 700) and incontinence products. Operates broadly in male urology as a larger incumbent, addressing Peyronie's, ED, and post-prostatectomy indications Andromedical also targets.
• Hims & Hers Health: Hims & Hers is a large direct-to-consumer men's health platform offering ED, hair loss, and wellness products via telehealth. Competes for the same end-consumer wallet share through digital marketing and subscription models, primarily with PDE5 generics.
• Coloplast: Coloplast is a global incumbent in urology and continence care with penile implants, vacuum devices, and catheter products. Comparable in indication coverage (ED, incontinence, post-surgery) and global medical-channel distribution.
• Endo International (Xiaflex): Endo markets Xiaflex (collagenase clostridium histolyticum), the only FDA-approved injectable for Peyronie's disease. A major competing therapeutic modality for Andromedical's Andropeyronie device in the same indication.

Direct peers

• Male Edge: Male Edge is a Danish penile traction device brand offering multiple sizes and CE-certified medical devices. Closely comparable product architecture, indication set, and DTC international distribution.
• Jes Extender (DanaMedic): Jes Extender is one of the longest-standing penile traction device brands globally, with a comparable product line and target indications. Competes head-to-head with Andropenis in the medical penis extender category through similar DTC channels.
• Osbon ErecAid (Timm Medical Technologies): Osbon ErecAid is a long-standing US vacuum erection device brand for erectile dysfunction. Directly comparable to Androvacuum in indication, regulatory pathway, and patient profile.
• SizeGenetics: SizeGenetics markets a medical-grade penile extender with a 58-way comfort system and clinical trial claims. Directly competes with Andropenis on penis enlargement and Peyronie's indications via global e-commerce.
• Quick Extender Pro: Quick Extender Pro is a US-marketed penis extender brand targeting enlargement and Peyronie's curvature correction. Competes on price and online visibility in the same end-consumer segment.
• Phallosan Forte: SwissSana's Phallosan Forte is a leading direct competitor offering a penile traction device with vacuum-belt technology. Highly comparable in clinical positioning, indication focus (enlargement, Peyronie's, post-surgery), and DTC e-commerce distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/Andropeyronie
• YouTubevimeo.com/andromedical
• Facebookfacebook.com/Andromedical
• Instagraminstagram.com/medicalextender
• Pinterestpinterest.com/andromedical
• LinkedInlinkedin.com/company/andromedical

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Andromedical